11 min listen
TNR Still’s Now Journal Club - Pivotal Trials in SJIA & AOSD Approved Meds
FromRheumnow Podcast
ratings:
Length:
59 minutes
Released:
Jul 27, 2022
Format:
Podcast episode
Description
This week's Stills disease Journal Club features expert discussants Drs. Olga Petryna, Daniel Lovell, Hermine Brunner and Jack Cush. Journal articles reviewed includes:
- CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease. Kedor C. Ann Rheum Dis 2020 Aug;79:1090-1097 https://bit.ly/3coPFg0
- TENDER Trial. Tocilizumab in systemic juvenile idiopathic arthritis. De Benedetti F. N Engl J Med. 2012 Dec 20;367:2385-95 https://bit.ly/3uXFq8Q
- CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease. Kedor C. Ann Rheum Dis 2020 Aug;79:1090-1097 https://bit.ly/3coPFg0
- TENDER Trial. Tocilizumab in systemic juvenile idiopathic arthritis. De Benedetti F. N Engl J Med. 2012 Dec 20;367:2385-95 https://bit.ly/3uXFq8Q
Released:
Jul 27, 2022
Format:
Podcast episode
Titles in the series (100)
The RheumNow Week in Review - 12 May 2017: The RheumNow Week in Review - 12 May 2017 by Dr. Cush by Rheumnow Podcast